THE TRINITY MEDICAL PRACTICE — All Prescriptions & Medications — Page 3
Practice Code: F81751 | CHELMSFORD, CM3 6AB
Showing results 101-150 of 512
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Combined ethinylestradiol 30mcg | 303 | 19.4K | £1.2K | +9.1% ▲ |
| Digoxin | 301 | 3,892 | £309 | -20.5% ▼ |
| 300 | 683 | £21.4K | -45.0% ▼ | |
| Methylphenidate hydrochloride | 286 | 9,170 | £9.1K | +10.7% ▲ |
| Atenolol | 279 | 5,936 | £251 | -53.7% ▼ |
| Fluticasone/umeclidinium/vilanterol | 264 | 265 | £11.1K | +12.6% ▲ |
| Insulin aspart | 256 | 2,100 | £12.2K | -32.8% ▼ |
| Hyoscine butylbromide | 253 | 14.0K | £981 | +8.6% ▲ |
| 250 | 3,300 | £1.9K | -62.4% ▼ | |
| Linagliptin | 243 | 4,116 | £4.6K | -40.7% ▼ |
| Empagliflozin | 243 | 3,801 | £4.7K | -61.2% ▼ |
| Diltiazem hydrochloride | 242 | 7,644 | £1.7K | -21.2% ▼ |
| Hydrocortisone | 240 | 6,925 | £1.1K | -46.5% ▼ |
| Alginic acid compound preparations | 239 | 92.3K | £1.7K | -59.2% ▼ |
| Etoricoxib | 239 | 3,332 | £998 | +196.6% ▲ |
| Insulin glargine | 237 | 1,620 | £11.2K | -16.5% ▼ |
| Loperamide hydrochloride | 235 | 23.6K | £516 | +0.9% vs avg |
| Doxycycline hyclate | 231 | 2,752 | £275 | -54.9% ▼ |
| Other emollient preparations | 231 | 126.7K | £1.8K | -61.5% ▼ |
| 231 | 126.0K | £1.3K | -76.5% ▼ | |
| Tacrolimus | 228 | 15.4K | £36.1K | +752.5% ▲ |
| 221 | 25.7K | £1.2K | -20.1% ▼ | |
| Ticagrelor | 219 | 5,082 | £5.0K | +157.5% ▲ |
| Topiramate | 216 | 7,768 | £1.0K | +21.5% ▲ |
| Clonazepam | 216 | 4,539 | £617 | +38.6% ▲ |
| Mirabegron | 216 | 4,045 | £3.7K | -46.2% ▼ |
| Glyceryl trinitrate | 212 | 315 | £505 | -10.4% ▼ |
| Flecainide acetate | 209 | 9,556 | £361 | +167.7% ▲ |
| Aripiprazole | 209 | 2,880 | £493 | -17.9% ▼ |
| Vitamin B compound | 207 | 5,229 | £173 | +48.6% ▲ |
| Hydroxychloroquine sulfate | 207 | 6,880 | £595 | +6.9% ▲ |
| Tiotropium bromide | 206 | 1,134 | £4.8K | -32.2% ▼ |
| Methotrexate | 206 | 3,978 | £3.8K | -36.7% ▼ |
| Perindopril erbumine | 201 | 6,326 | £572 | -62.1% ▼ |
| Etodolac | 196 | 4,700 | £2.3K | +607.9% ▲ |
| Budesonide | 194 | 215 | £5.3K | -64.2% ▼ |
| Latanoprost | 194 | 2,158 | £1.6K | -60.0% ▼ |
| Famotidine | 192 | 3,892 | £2.4K | -60.6% ▼ |
| Buprenorphine | 191 | 832 | £3.7K | -47.9% ▼ |
| Bezafibrate | 185 | 6,533 | £902 | +243.5% ▲ |
| Zolpidem tartrate | 185 | 1,820 | £91 | +105.3% ▲ |
| Estradiol | 182 | 4,424 | £2.6K | -32.5% ▼ |
| Mycophenolate mofetil | 182 | 5,372 | £3.1K | +349.5% ▲ |
| Nifedipine | 181 | 4,290 | £865 | -3.4% ▼ |
| Mesalazine (Systemic) | 174 | 18.7K | £9.4K | -27.4% ▼ |
| Alfacalcidol | 171 | 5,249 | £581 | +38.3% ▲ |
| Olanzapine | 170 | 2,940 | £296 | -54.1% ▼ |
| Warfarin sodium | 162 | 7,288 | £251 | -65.6% ▼ |
| Levetiracetam | 158 | 8,328 | £3.8K | -65.5% ▼ |
| Azathioprine | 158 | 7,728 | £183 | +45.8% ▲ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.